自适应航天器态势分析系统

利用深度学习中的卷积神经网络理论,基于单目视觉系统和带有标识物的航天器影像,实现对航天器的三维姿态角、距拍摄点距离和相对拍摄中心偏移量的精准测量。利用机器学习理论实现网络自主学习样本特征,这一方式将大幅降低动态测量的误差。同时,这种测量方式也避免了人工提取特征的复杂过程,实现任意、精准、快速测量,对航天器在组装及发射过程中的姿态估计、距离测算起到关键性作用。     

河北省外贸企业应对技术性贸易壁垒的对策研究

技术性贸易壁垒一方面严重制约了河北省对外贸易的正常发展,同时也给河北省的对外贸易带来难得的发展机遇.对于一个个市场主体而言,技术进步是突破技术性贸易壁垒制约的关键,市场多元化是突破技术性贸易壁垒制约的重要方法.     

基于STFRFT的LFM引信抗欺骗干扰方法

针对线性调频脉冲压缩引信易受转发式假目标欺骗干扰问题,提出了基于短时分数阶傅立叶变换(STFRFT)的抗欺骗干扰方法。首先,通过分数阶傅立叶变换将回波信号与欺骗干扰各分量信号进行分离;再利用相同调频率的LFM信号经短时分数阶傅立叶变换后最大幅值与窗函数宽度成线性关系,而不同调频率的最大幅值不随窗函数宽度变化的特点,有效分辨假目标欺骗干扰,正确检测目标回波信号;最后,通过仿真证明了方法的正确性,并验证所提方法具有良好的抗欺骗干扰效果。     

微量钪对Al-Zn-Mg-Zr焊接接头组织性能的影响

采用铸锭冶金法制备了 Al-6.0Zn-2.0Mg-0.12Zr 和 Al- 6.0Zn - 2.0Mg - 0.2Sc - 0.12Zr 两种合金板材,以 Al-Mg-Sc-Zr焊丝为焊接填充材料,对3 mm厚的上述两种合金板材进行氩弧焊接,之后对两种接头的显微组织和力学性能进行对比研究.结果表明:第一,微量Sc可以显著提高Al-Zn-Mg-Zr合金基材的拉伸性能,基材强度的提高来源于晶粒细化强化、Al3(Sc,Zr)粒子的析出强化和Al3(Sc,Zr)粒子引起的亚结构强化;第二,焊接过程中,不含 Sc 的合金焊接接头热影响区内η相(MgZn2)粒子和晶粒明显粗化,含 Sc的合金焊接接头热影响区内η相(MsZn2)粒子也明显粗化,但晶粒大小没有明显变化,由于Al3(Sc、Zr)粒子稳定性高,不容易粗化和团聚,对位错和亚晶界仍然起钉扎作用,热影响区仍然保持未再结晶组织,过时效软化现象相对于传统的铝镁合金来说不是很严重;第三,微量 Sc 可以明显提高 Al-Zn-Mg-Zr 合金焊接接头的强度,与不加 Sc 的合金焊接接头相比,添加Sc的合金拉伸强度从395 MPa提高到447 MPa,强度系数从 0.7 提高到0.8.强度的提高主要来源于晶粒细化强化、Al3(Sc,Zr)粒子的析出强化和由于Al3(Sc,Zr)粒子的高稳定性导致的的抗热循环软化能力的提高.     

硝酸酯增塑的热塑性聚氨酯弹性体推进剂

研究了在热塑性聚氨酯弹性体 (TPU )软段中引入聚乙二醇 (PEG) ,以改善与硝酸酯的混溶能力。通过控制 PEG的相对分子质量和含量 ,可使硝酸酯与 TPU的混溶比大于 4。采用溶剂法挤压成型工艺成功地制成了硝酸酯增塑的 TPU推进剂。此类推进剂的理论比冲为 2 598N· s/kg～ 2 648N· s/kg,燃烧性能优良 ,空白配方的压力指数为 0 .36,常、低温力学性能优异 ,可为硝酸酯增塑 ,加工温度较低。该推进剂是一个可以实现以挤压工艺生产的复合推进剂新品种 ,具有良好的应用前景。此外 ,对推进剂的热分解性能也进行了研究     

F-12 纤维/RE14复合材料压力容器成型工艺研究

研究讨论了缠绕过程中几种主要工艺参数对F— 12纤维 /RE14配方Φ15 0mm压力容器复合材料性能的影响。结果表明 :采用“交替”铺层方式缠绕成型 ,含胶量控制在 30 %～ 4 0 % (质量分数 ) ,缠绕张力控制在 15 0N～ 2 0 0N ,采用GPC谱图控制固化时机 ,得到的复合材料综合性能较好 ;用优化出的工艺参数进行了Φ4 80mm压力容器试验 ,结果表明其容器特性系数PV/W值为 37.0 2km ,纤维强度转化率高达73.2 6 %。     

财务杠杆的使用条件研究及其与营业杠杆组合的效应分析

本文在阐述财务杠杆一般原理的基础上，对财务杠杆的使用条件进行了深入研究。结合量本利分析给出了财务杠杆所要求的最低生产规模。系统分析了财务杠杆和营业杠杆复合作用下股份盈利模型的使用条件及应用价值。     

国际合作,共研歼八ⅡM型飞机

歼八Ⅱ型飞机是出口型飞机,该机主要突出雷达火控系统综合作战能力,为此,该机确定配置先进的PD雷达。经过技术、经济、进度的综合论证,选定俄罗斯的“甲虫”雷达。通过我所与俄方多次技术协调与谈判,确定俄方在“甲虫”雷达基础上按我方技术要求     

Space motion sickness

Space motion sickness, presumably triggered by sudden entry into a weightless environment, occurred with unexpected frequency and severity among astronauts who flew the Skylab missions. Recovery from symptoms was complete within 3-5 days, and as revealed by the Skylab M131 Human Vestibular Function Experiment, all crewmembers were immune to experimentally induced motion sickness after mission day 8. This syndrome has been recognized as a possible threat to the early mission well-being and operational efficiency of at least some individuals who will fly space missions in the future. The causes of space motion sickness are not clearly understood, nor have satisfactory methods been identified to date for its prediction, prevention and treatment. In order to minimize the potential impact of this syndrome on Space Shuttle crew operations the National Aeronautics and Space Administration has organized a broad program of inter-disciplinary research involving a large number of scientists in the United States. Current research on the etiology of space motion sickness is based to a large extent on the so called sensory conflict theory. Investigations of the behavioral and neurophysiological consequences of intralabyrinthine, as well as intermodality sensory conflict are being performed. The work in this area is being influenced by the presumed alterations that occur in otolith behavior in weightlessness. In addition to sensory conflict, the possible relationship between observed cephalad shifts of body fluids in weightlessness and space motion sickness is being investigated. Research to date has failed to support the fluid shift theory. Research underway to identify reliable test methods for the prediction of susceptibility to space motion sickness on an individual basis includes attempts to (a) correlate susceptibility in different provocative environments; (b) correlate susceptibility with vestibular and non-vestibular response parameters, the latter including behavioral, hemodynamic and biochemical factors and (c) correlate susceptibility with rate of acquisition and length of retention of sensory adaptation. Controlled studies are also being performed during parabolic flight as a means of attempting to validate predictive tests for susceptibility to this syndrome. Research to develop new or improved countermeasures for space motion sickness is underway in two primary areas. One of these involves anti-motion sickness drugs. Significant achievements have been realized with regard to the identification of new highly efficacious drug combinations, dose levels and routes of administration. Although pronounced individual variations must be accounted for in selecting the optimum drug and dose level, combinations of promethazine plus ephedrine or scopolamine plus dexidrine are presently the drugs of choice. Work is also underway to identify side effects associated with anti-motion sickness drug use and to identify new drugs which may selectively modify activity in central neural pathways involved in motion sickness. In addition to research on drugs, efforts are being made to develop practical vestibular training methods. Variables which influence rate of acquisition of adaptation, length of retention of adaptation and transfer of protective adaptation to new environments are being evaluated. Also, included in this area is the use of biofeedback and autogenic therapy to train individuals to regulate autonomic responses associated with motion sickness. While valuable new knowledge is expected to evolve from these combined research programs, it is concluded that the final validation of predictive tests and countermeasures will require a series of controlled space flight experiments.